Evidence map›Paper›PMID 20720183›Full record

ArticleBlood2010

Dose-dependent regulation of primitive erythroid maturation and identity by the transcription factor Eklf.

Joan Isern, Stuart T Fraser, Zhiyong He, Hailan Zhang, Margaret H Baron

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Development and differentiation of the erythroid lineage in mammals.Developmental and comparative immunology · 2016
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Erythroid development in the mammalian embryo.Blood cells, molecules & diseases · 2013
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Joan IsernDepartment of Medicine, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.
Stuart T Fraser
Zhiyong He
Hailan Zhang
Margaret H Baron
Cancer Institute (WIA) · INStem Cell Institute · PATisch Cancer InstituteTisch Hospital · US

Funding

Induction and Specification of Hematopoietic MesodermR01HL062248 · NHLBI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BARON, MARGARET H · 2000 to 2016
$5.5M
INDUCTION OF YOLK SAC HEMATOPOIETIC MESODERM BY BMP-4R01DK052191 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BARON, MARGARET H · 1997 to 2011
$4.2M
Methods for Modulating Hemato-Vascular DevelopmentR01EB002209 · NIBIB · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BARON, MARGARET H. · 2003 to 2007
$1.7M
GENE KNOCKOUT/TRANSGENIC ANIMAL SHARED RESOURCER24CA088302 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI KELLEY, KEVIN A · 2001 to 2005
$767k
NCI NIH HHS R24 CA088302NHLBI NIH HHS R01 HL062248NHLBI NIH HHS R01 HL62248NIBIB NIH HHS EB02209NIBIB NIH HHS R01 EB002209NIDDK NIH HHS DK52191NIDDK NIH HHS R01 DK052191
6 · The paper itself

Abstract

The primitive erythroid (EryP) lineage is the first to differentiate during mammalian embryogenesis. Eklf/Klf1 is a transcriptional regulator that is essential for definitive erythropoiesis in the fetal liver. Dissection of the role(s) of Eklf within the EryP compartment has been confounded by the simultaneous presence of EryP and fetal liver-derived definitive erythroid (EryD) cells in the blood. To address this problem, we have distinguished EryP from their definitive counterparts by crossing Eklf(+/-) mutant and ε-globin::histone H2B-GFP transgenic mice. Eklf-deficient EryP exhibit membrane ruffling and a failure to acquire the typical discoidal erythroid shape but they can enucleate. Flow cytometric analyses of H2B-GFP(+) EryP revealed that Eklf heterozygosity results in the loss of Ter119 surface expression on EryP but not on EryD. Null mutation of Eklf resulted in abnormal expression of a range of surface proteins by EryP. In particular, several megakaryocyte markers were ectopically expressed by maturing Eklf-null EryP. Unexpectedly, the platelet tetraspanin CD9 was detected on nucleated wild-type EryP but not on mature EryD and thus provides a useful marker for purifying circulating EryP. We conclude that Eklf gene dosage is crucial for regulating the surface phenotype and molecular identity of maturing primitive erythroid cells.

Indexed as

AnimalsAntigens, CDBase SequenceBlood Group AntigensDNA PrimersErythroid Precursor CellsErythropoiesisFemaleFetusHaploinsufficiencyHumansKruppel-Like Transcription FactorsLiverMegakaryocytesMembrane GlycoproteinsMiceAntigens, CDBlood Group AntigensCD9 protein, humanCd9 protein, mouseDNA Primerserythroid Kruppel-like factorKruppel-Like Transcription FactorsMembrane GlycoproteinsTER-119 antigen, mouseTetraspanin 29

Identifiers

PMID20720183
PMCPMC2981545
OpenAlexW2043259929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.